Niaz Ahmed's research group
Stroke- Acute intervention and secondary prevention
Stroke is the number one cause of neurological disability in adults and the second leading cause of death worldwide. Around 85% of stroke cases are caused by cerebral infarcts due to occlusion of cerebral arteries, 15% are caused by spontaneous intracerebral haemorrhages.
Links to partner sites
SITS – Safe Implementation of Treatments in Stroke.
A non-profit, research-driven, independent, international collaboration. It’s an initiative by the medical profession to assure excellence in acute treatment and secondary prevention of stroke, as well as to facilitate clinical trials.
I-Stroke II is an academic driven, multicentre, prospective, randomised, double-blind, parallel-group, placebo-controlled, multicentre efficacy trial of Imatinib in acute ischaemic stroke.